Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3040562	pd-diffi	— (—)	132	1112	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Glomerular diseases

101

102.23

195.29

8.6

11.4

—

Dialysis

130

+∞

137.54

8.5

0.0

—

Nephropathy related operations

131

+∞

137.07

8.5

0.0

—

Dialysis, with operation codes

131

+∞

137.03

8.5

0.0

—

Chronic kidney disease

131

+∞

134.61

8.5

0.0

—

Care involving dialysis

127

+∞

133.20

8.7

0.0

—

Renal failure

131

+∞

128.29

8.5

0.0

—

All chronic kidney diseases

131

+∞

124.91

8.5

0.0

—

L04AA Selective immunosuppressants

60.36

118.32

8.2

6.2

—

Diabetic nephropathy

62.78

112.41

10.7

8.4

—

Acute peritonitis

+∞

95.37

11.0

0.0

—

ILD medications: immunosuppressive drugs

19.43

90.43

8.4

8.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

18.31

76.78

8.1

9.6

—

Insulin, fast-acting

18.79

76.02

11.2

8.2

—

Heart failure, not strict

92.33

75.35

8.7

9.0

—

Glomerular disorders in diseases classified elsewhere

93.78

75.12

9.4

12.4

—

Insulin, fast-acting or short human

17.69

73.91

11.2

8.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

13.82

71.35

7.4

10.4

—

L04AD Calcineurin inhibitors

144.13

67.08

8.1

11.4

—

Other bacterial diseases

13.59

66.65

9.0

8.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

13.11

64.66

11.0

7.4

—

Insulin medication

13.50

62.29

11.0

7.5

—

Insulin, intermediate and long-acting

13.03

59.55

11.3

7.6

—

Type 1 diabetes

20.49

59.10

11.1

8.0

—

Septicaemia

17.56

57.85

9.5

9.2

—

Type 1 diabetes, wide definition

21.55

57.66

11.3

8.6

—

Aplastic and other anaemias

14.00

57.00

6.6

9.3

—

Other septicaemia

18.50

56.88

9.7

7.0

—

Bacterial infection, other or unspecified

16.58

56.81

9.6

10.8

—

Other septicaemia, including avohilmo

18.41

56.59

9.7

7.0

—

Bacterial infection, other or unspecified, including avohilmo

16.40

56.51

9.6

10.8

—

Sub-endpoint used in defining T1D endpoints

15.99

54.50

10.7

9.6

—

Type 1 diabetes, wide definition, subgroup 1

20.55

53.88

11.1

8.6

—

Explicit Sepsis

14.54

53.76

9.4

9.8

—

Explicit Sepsis, including avohilmo

14.47

53.47

9.4

9.8

—

ILD medications: prednisolone, methylprednisolone, prednisone

11.41

53.09

8.1

8.9

—

Diabetic retinopathy, strict definition

22.87

51.80

10.7

9.6

—

Other bacterial diseases, including avohilmo

10.81

50.59

8.2

—

Peripheral artery disease

15.82

50.23

10.2

9.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

16.81

48.33

10.5

7.3

—

Diseases of arteries, arterioles and capillaries

11.82

47.98

10.3

9.9

—

Hypertensive diseases

63.04

47.28

7.9

7.2

—

Hypertension

63.03

47.27

7.9

7.2

—

ILD medications

10.50

47.25

8.1

8.9

—

Disorders of other endocrine glands

11.93

45.25

7.0

9.0

—

Metabolic disorders

10.83

45.24

8.6

8.5

—

Other disorders of kidney and ureter

57.94

39.28

8.1

8.8

—

First line medication for Crohn's disease

8.88

38.23

7.9

8.9

—

All-cause Heart Failure

10.88

38.22

9.7

10.2

—

Heart failure,strict

68.48

37.98

9.9

10.0

—

Heart failure, strict

10.54

37.50

9.7

9.9

—

Heart failure and coronary heart disease

13.39

36.02

10.3

10.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7.97

35.41

9.2

8.4

—

Implicit Sepsis

8.99

35.00

9.0

9.5

—

Bacterial Sepsis

10.94

34.75

9.8

—

Acute renal failure

+∞

34.39

9.5

0.0

—

Hypertension, essential

47.14

34.05

9.4

7.2

—

Diarrhoea and gastroenteritis of presumed infectious origin

7.57

33.80

9.0

7.4

—

Other disorders of fluid, electrolyte and acid-base balance

44.02

33.66

7.8

10.3

—

Implicit bacterial Sepsis

11.76

33.42

10.1

10.6

—

Other retinal disorders

7.75

33.20

10.0

9.8

—

Endocrine, nutritional and metabolic diseases

20.70

32.90

9.0

5.3

—

Heart failure and antihypertensive medication

+∞

32.38

10.6

0.0

—

Acute tubulo-interstitial nephritis

+∞

32.17

11.6

0.0

—

Ischemic heart diseases

8.85

31.97

9.6

4.8

—

Type 2 diabetes, wide definition

9.09

31.70

10.7

8.6

—

Coronary atherosclerosis

12.32

31.55

9.6

6.2

—

Erysipelas

11.61

31.47

10.5

11.1

—

Statin medication

14.43

31.44

8.0

6.6

—

Glomerulonephritis

46.61

30.58

5.2

9.9

—

Implicit bacterial Sepsis, including avohilmo

10.27

30.21

10.1

—

Other disorders of skin and subcutaneous tissue

7.11

30.04

10.8

8.7

—

Erysipelas, including avohilmo

10.32

29.98

9.8

10.5

—

Amputation

68.35

29.89

12.7

5.8

—

Implicit Sepsis, including avohilmo

7.79

29.86

9.1

—

Other and unspecified anaemias

9.96

29.83

7.8

9.8

—

Other anaemias

9.93

29.73

7.8

9.8

—

Ulcer of lower limb, not elsewhere classified

45.20

29.60

9.9

12.6

—

Gout

12.69

29.24

8.9

14.0

—

Diabetic retinopathy

9.44

28.87

10.1

9.2

—

Other heart diseases, wide

7.49

28.79

8.6

8.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

+∞

28.73

9.4

0.0

—

Dental caries

32.67

28.72

7.8

10.9

—

Disorders of choroid and retina

6.63

28.66

10.0

9.4

—

Disorders of lens

8.65

28.55

8.5

9.7

—

Covid-19 confirmed case

9.19

28.18

9.7

8.1

—

Intestinal infectious diseases

5.81

28.11

9.5

7.7

—

Persons encountering health services in other circumstances, wide

6.89

28.06

8.5

8.4

—

GASTRO-related operations

+∞

28.06

9.4

0.0

—

Any gastric operation

+∞

28.06

9.4

0.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

7.19

27.84

9.2

8.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

7.40

27.67

8.8

9.1

—

Percutaneous Coronary Intervention

8.23

27.31

10.3

4.9

—

Coronary revascularization (ANGIO or CABG)

8.22

27.27

10.5

4.9

—

Hard cardiovascular diseases

7.88

27.21

10.2

7.9

—

Unspecified kidney failure

+∞

27.10

4.8

0.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

7.21

26.91

8.4

6.8

—

Autoimmune diseases excluding thyroid diseases

6.97

26.68

8.7

7.5

—

Emergency coronary revascularization (for ACS)

7.02

26.34

10.7

6.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

7.34

26.25

9.2

7.2

—

7.34

26.25

9.2

7.2

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

6.88

26.19

9.5

7.3

—

Major coronary heart disease event

7.36

26.09

10.1

7.2

—

Caries of dentine

32.86

25.95

7.5

11.9

—

Other cataract

10.12

25.85

8.6

11.3

—

Diabetes, varying definitions

6.70

25.85

9.1

7.2

—

Diabetes mellitus

6.67

25.71

9.1

7.2

—

Diabetic retinopathy, excluding more controls

36.50

25.47

9.0

3.5

—

Hyperparathyroidism

35.28

25.02

7.3

8.1

—

Disorders of parathyroid gland

35.24

25.01

7.3

8.1

—

Diabetes, insulin treatment (Kela reimbursement)

6.18

24.99

9.4

6.8

—

Provisional assignment of new diseases of uncertain etiology

6.85

24.68

9.2

7.9

—

Codes for special purposes

6.85

24.67

9.2

7.9

—

Disorders of lipoprotein metabolism and other lipidaemias

9.24

24.35

9.8

9.5

—

Amputation of toe

56.49

24.03

10.0

9.8

—

Infections of the skin and subcutaneous tissue

5.99

23.93

7.9

8.6

—

Ischaemic heart disease, wide definition

7.60

23.76

9.0

9.4

—

Insulin, fast-acting (human)

31.13

23.66

11.2

13.7

—

Bleeding

5.73

23.30

9.3

9.2

—

Polyarthropathies

6.43

23.29

9.7

9.0

—

Peripheral arterial reconstruction

36.37

22.95

10.6

7.3

—

All pneumoniae

5.18

22.91

9.9

6.9

—

Fever of other and unknown origin

7.09

22.77

9.9

7.3

—

Pneumonia, organism unspecified

5.44

22.42

10.2

6.9

—

Pneumonias (Asthma/COPD co-morbidities)

5.11

22.25

9.9

7.0

—

Diabetes medication

5.84

22.25

9.5

6.7

—

Type 2 diabetes

6.51

21.88

9.7

7.9

—

Influenza and pneumonia

4.97

21.12

9.9

6.7

—

Presence of other functional implants

9.93

20.81

9.5

11.3

—

Complications of surgical and medical care, not elsewhere classified

4.93

20.46

8.2

9.6

—

Autoimmune diseases

5.78

20.16

8.1

7.4

—

Diabetic maculopathy, excluding more controls

27.13

20.00

11.8

10.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.74

19.99

9.9

7.9

—

Certain infectious and parasitic diseases

9.23

19.93

9.1

8.4

—

ILD medications: azathioprine

46.11

19.17

6.7

7.2

—

Vitreous haemorrhage

26.14

19.10

9.6

7.3

—

Gout, FINNGEN

14.02

18.43

8.9

9.7

—

Hyperlipidaemia, other/unspecified

17.39

18.29

11.5

13.9

—

Myocardial infarction

9.71

17.89

8.7

6.6

—

Used for control exclusion in common control thyroid runs

5.69

17.82

8.5

6.7

—

Hernia of abdominal wall, postoperative

+∞

17.66

13.1

0.0

—

Diabetic maculopathy

18.29

17.57

11.8

10.1

—

Hypertensive Renal Disease

+∞

16.69

6.9

0.0

—

Gout, idiopatic and unspecified

13.36

16.41

9.3

10.3

—

Cerebrovascular diseases (FINNGEN)

+∞

16.26

7.1

0.0

—

Major coronary heart disease event excluding revascularizations

7.39

16.12

8.3

9.7

—

Heart failure and bmi 25plus

8.34

15.79

10.0

11.2

—

Any reimbursement code in KELA

+∞

15.58

9.4

0.0

—

Implicit viral Sepsis

19.20

15.51

7.5

5.8

—

Viral Sepsis

19.20

15.51

7.5

5.8

—

Senile cataract

6.50

15.48

9.3

10.4

—

Azathioprine

17.74

15.11

6.7

6.9

—

Inflammatory bowel disease treatment related agents

3.95

15.10

7.2

9.4

—

Gout, unspecified

14.15

14.50

10.1

11.6

—

Implicit viral Sepsis, including avohilmo

11.29

14.21

7.8

8.6

—

COPD/asthma/ILD related infections

5.01

14.06

8.8

7.2

—

COPD/asthma related infections

5.01

14.06

8.8

7.2

—

Cardiac arrhythmias

8.19

14.05

8.2

4.9

—

Atrial fibrillation and flutter

+∞

13.96

10.1

0.0

—

STROKE

21.16

13.75

8.3

5.4

—

Acute upper respiratory infections of multiple and unspecified sites

4.53

13.70

7.1

8.2

—

Complications of procedures, not elsewhere classified

4.33

13.46

9.7

9.8

—

Tramadol

4.89

13.42

7.5

7.8

—

Complications of medical and surgical care

4.19

13.05

9.3

9.2

—

Non-rheumatic valve diseases

7.49

12.71

9.0

10.8

—

Adjustment and management of implanted device

+∞

12.50

8.3

0.0

—

Disorders of vitreous body

4.94

12.47

9.3

9.2

—

Any death

4.66

12.42

8.8

10.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3.79

12.31

9.7

7.7

—

Certain disorders involving the immune mechanism

11.60

12.28

7.8

9.5

—

Bronchitis

3.66

12.03

8.6

8.7

—

Valvular heart disease excluding rheumatic fever

6.55

11.96

9.5

9.3

—

Gout, strict definition

11.69

11.79

8.8

11.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.50

11.73

10.3

8.4

—

Disorders of vitreous body and globe

4.64

11.60

9.3

9.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

3.53

11.39

10.5

7.7

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.49

11.34

10.6

6.9

—

Dermatitis

4.23

11.26

8.2

8.1

—

Angina pectoris

6.98

11.07

8.6

6.8

—

Fitting and adjustment of other devices

+∞

10.91

4.8

0.0

—

Iron deficiency anaemia

5.14

10.74

11.1

8.3

—

Fluid overload

+∞

10.57

9.6

0.0

—

3.65

10.47

9.8

8.5

—

Nutritional anaemias

4.67

10.43

11.6

7.7

—

Other CVD (FINNGEN)

+∞

10.30

6.9

0.0

—

Osteomyelitis

23.44

10.23

10.3

7.3

—

Viral and other specified intestinal infections

9.31

10.05

6.8

9.6

—

Other disorders of glucose regulation and pancreatic internal secretion

14.60

9.98

11.9

7.7

—

Hypothyroidism, strict autoimmune

5.08

9.97

8.5

7.7

—

Other acute lower respiratory infections

4.20

9.93

9.1

7.9

—

Diseases of the skin and subcutaneous tissue

3.97

9.63

8.6

6.5

—

Acute upper respiratory infections

3.39

9.62

8.8

8.7

—

Nausea and vomiting

8.49

9.57

6.4

7.0

—

Charcot foot

+∞

9.39

13.3

0.0

—

Chronic tubulo-interstitial nephritis

+∞

9.38

10.3

0.0

—

Second line medication for Crohn's disease

3.85

9.35

6.5

8.5

—

Other and unspecified dermatitis

4.34

9.31

8.1

—

Oral corticosteroids

3.26

9.26

9.0

9.4

—

COPD differential diagnosis

5.01

9.09

10.6

7.0

—

ILD differential diagnosis

5.01

9.09

10.6

7.0

—

Excluding asthma or asthma-COPD overlap

5.01

9.09

10.6

7.0

—

L04AX Other immunosuppressants

3.82

8.92

6.7

8.6

—

Osteopathies and chondropathies

4.01

8.91

9.7

8.6

—

Chronic apical periodontitis

3.20

8.91

9.3

8.0

—

Viral and other specified intestinal infections, including avohilmo

7.41

8.84

6.7

8.5

—

Dermatitis and eczema

2.99

8.79

9.7

8.0

—

Myocardial infarction, strict

7.87

8.60

9.3

6.6

—

Factors influencing health status and contact with health services

+∞

8.58

8.3

0.0

—

Other functional intestinal disorders

4.44

8.49

8.4

6.9

—

Cerebrovascular diseases

3.59

8.47

7.2

10.6

—

General symptoms and signs

3.40

8.40

8.9

6.5

—

Myocardial infarction, without ST-elevation

4.41

8.40

7.6

9.6

—

Hydronephrosis

+∞

8.33

5.8

0.0

—

Abdominal and pelvic pain

3.35

8.23

8.0

9.8

—

Diseases of the digestive system

4.04

8.14

8.1

8.7

—

Diseases of the eye and adnexa

4.10

7.99

7.5

8.8

—

Non-ischemic cardiomyopathy

10.82

7.90

8.7

11.6

—

Hypoglycaemia, other or unspecified

13.05

7.87

9.5

5.1

—

Cutaneous abscess, furuncle and carbuncle

6.07

7.82

9.8

9.4

—

Other pulmonary diagnosis

4.61

7.73

10.4

7.0

—

Cellulitis

6.68

7.57

6.0

9.7

—

Other CVD

10.01

7.52

7.7

9.1

—

Oedema, not elsewhere classified

7.22

7.51

11.3

7.9

—

Obesity due to excess calories

3.80

7.50

12.4

7.2

—

Idiopathic gout

13.37

7.38

10.0

10.9

—

Opioids

3.41

7.37

9.2

7.4

—

Failure and rejection of transplanted organs and tissues

+∞

7.31

3.3

0.0

—

Tubulo-interstitial nephritis, not specified as acute or chronic

+∞

7.29

11.0

0.0

—

General examination and investigation of persons without complaint and reported diagnosis

3.86

7.28

6.6

10.1

—

Hypotension

10.85

7.28

7.9

6.7

—

Other problems related to primary support group, including family circumstances

12.99

7.25

2.3

6.6

—

Pure hypercholesterolaemia

4.97

7.24

8.3

10.2

—

Acute bronchitis

4.05

7.04

8.7

8.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.76

7.00

9.2

10.1

—

Certain infectious and parasitic diseases, including avohilmo

5.68

6.95

10.6

8.7

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.75

6.90

11.0

9.7

—

Symptoms and signs involving the digestive system and abdomen

3.06

6.67

7.9

9.8

—

Other diseases of hard tissues of teeth

5.53

6.50

3.6

8.7

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

6.74

6.44

3.9

8.8

—

Coronary artery bypass grafting

11.12

6.40

9.1

4.1

—

Congenital malformations of the urinary system

14.34

6.39

5.3

4.3

—

Congenital malformations of the urinary system, including avohilmo

14.33

6.39

5.3

4.3

—

Other nutritional deficiencies

3.08

6.39

12.0

8.3

—

Sulfonylureas

5.87

6.34

11.2

7.8

—

All influenza

6.53

6.32

9.1

7.0

—

Fitting and adjustment of external prosthetic device

+∞

6.30

13.7

0.0

—

Other local infections of skin and subcutaneous tissue

11.02

6.29

8.1

9.0

—

Iron deficiency anaemia secondary to blood loss (chronic)

9.24

6.28

11.0

6.3

—

Microscopic polyangiitis

+∞

6.28

1.5

0.0

—

Abnormal findings on examination of urine, without diagnosis

18.08

6.26

9.2

8.4

—

Hernia of abdominal wall

3.66

6.18

11.9

9.0

—

Other specified/unspecified arthritis

6.26

6.15

9.7

8.7

—

Viral infections characterized by skin and mucous membrane lesions

3.51

6.13

5.0

8.3

—

Abnormalities of breathing

2.91

6.07

7.4

8.7

—

Viral pneumonia

10.01

6.02

14.6

7.3

—

Medical observation and evaluation for suspected diseases and conditions

3.50

5.96

8.0

10.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3.12

5.94

9.0

9.6

—

Invasive ventilation

15.03

5.90

8.0

7.3

—

Enterocolitis due to Clostridium difficile

15.02

5.90

16.9

7.2

—

Special screening examination for other diseases and disorders

15.00

5.89

5.8

9.7

—

Persons encountering health services in other circumstances

7.15

5.86

11.8

8.7

—

Asthma (only as main-diagnosis), excluding more controls

4.47

5.82

6.8

7.7

—

Other and unspecified local infections of skin and subcutaneous tissue

11.13

5.79

8.4

9.9

—

Other bacterial intestinal infections

9.18

5.78

16.3

7.4

—

Persons with potential health hazards related to communicable diseases

3.49

5.78

5.4

8.6

—

Presence of cardiac and vascular implants and grafts

6.13

5.74

8.5

11.4

—

Dyspnoea

2.69

5.71

7.5

9.6

—

Parasetamol

3.37

5.64

10.2

8.4

—

Diseases of oesophagus, stomach and duodenum

2.53

5.58

10.6

7.9

—

Explicit bacterial Sepsis

12.87

5.57

9.2

6.6

—

Explicit bacterial Sepsis, including avohilmo

12.87

5.57

9.2

6.6

—

Stroke, including SAH

3.07

5.54

7.0

11.1

—

Other disorders of optic [2nd] nerve and visual pathways

16.05

5.41

5.8

5.2

—

Pruritus

16.02

5.41

7.3

2.8

—

Other arthritis (FG)

5.18

5.38

9.7

8.2

—

Conduction disorders

7.40

5.35

9.8

11.8

—

Pain in limb

2.68

5.32

8.6

8.3

—

Malaise and fatigue

3.72

5.31

10.1

7.6

—

Pleural effusion

9.10

5.28

6.1

7.3

—

Other bacterial intestinal infections, including avohilmo

6.67

5.24

17.7

8.1

—

Unspecified contracted kidney

+∞

5.23

10.0

0.0

—

Gout due to impairment of renal function

+∞

5.22

6.8

0.0

—

Asthma, excluding more controls

4.15

5.22

5.9

7.7

—

Other localized connective tissue disorders

+∞

5.21

4.2

0.0

—

Atrial fibrillation and flutter with reimbursement

+∞

5.18

14.0

0.0

—

Streptococcal septicaemia

13.36

5.07

10.1

7.3

—

Streptococcal septicaemia, including avohilmo

13.36

5.07

10.1

7.3

—

Unspecified haematuria

3.41

5.05

10.7

8.7

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

10.01

5.02

4.4

11.8

—

Hypothyroidism, other/unspecified

2.73

5.00

9.8

8.3

—

Other diseases of intestines

2.44

4.99

8.4

7.9

—

Codeine

2.94

4.93

8.5

7.6

—

Oxycodone

4.75

4.91

9.4

7.4

—

Stroke, excluding SAH

2.91

4.89

7.3

10.9

—

Asthma (only as main-diagnosis)

3.80

4.87

6.8

7.0

—

Diseases of pulp and periapical tissues, including avohilmo

2.55

4.86

9.9

6.4

—

Autoimmune diseases related-to ILD

2.50

4.82

5.9

9.6

—

Acute sinusitis

3.36

4.81

8.7

7.4

—

Finngen Rheumatological endpoints

2.58

4.81

7.0

9.0

—

Disorders of tooth development and eruption

13.02

4.80

3.4

19.8

—

Trigger finger

9.01

4.78

13.3

13.7

—

Other diseases of pleura

3.12

4.74

10.0

9.2

—

Other diseases of the digestive system

4.41

4.73

8.3

9.0

—

GI-bleeding

4.41

4.73

8.3

9.0

—

Symptoms and signs involving the circulatory and respiratory systems

2.55

4.67

8.2

8.7

—

Umbilical hernia

4.67

11.4

8.3

—

Bacterial intestinal infections, IBD co-morbidities

6.12

4.59

16.3

6.2

—

Sequelae with surgical and medical care as external cause

5.46

4.59

10.5

8.1

—

Disorders of optic nerve and visual pathways

10.02

4.52

5.8

5.9

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.67

4.49

9.1

8.3

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.56

4.47

9.8

8.1

—

Obesity

2.72

4.47

12.4

8.5

—

Obesity and other hyperalimentation

2.72

4.45

12.4

8.5

—

Use of pramipexole

5.79

4.43

7.7

9.3

—

Systemic connective tissue disorders

4.38

4.42

4.6

8.9

—

Bacterial pneumonia, not elsewhere classified

4.39

4.35

9.4

8.0

—

Exposure to unspecified factor

2.27

4.30

13.1

6.9

—

Asthma

3.51

4.29

5.9

7.0

—

Other (not insulin) diabetes medications

2.93

4.28

8.1

7.6

—

AV-block

7.69

4.28

11.2

8.3

—

Abnormal results of function studies

11.68

4.27

11.4

5.3

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6.90

4.27

6.9

12.5

—

Bacterial pneumoniae

4.24

4.22

9.4

7.8

—

Chronic periodontitis, including avohilmo

2.36

4.21

6.8

10.0

—

Periodontitis

2.36

4.20

6.8

10.0

—

Diseases of pulp and periapical tissues and dental caries

3.30

4.17

6.7

5.3

—

Pacemaker

3.87

4.17

9.6

7.9

—

Other diseases of intestine

6.93

4.16

6.4

6.8

—

Disorders of the thyroid gland

2.42

4.16

9.5

8.7

—

Gastroduodenal ulcer

5.22

4.12

9.4

9.0

—

Sequelae of external causes of morbidity and mortality

4.34

4.12

10.1

8.7

—

Myocardial infarction, unclassifiable

5.96

4.08

9.3

7.7

—

Cardiomyopathy

8.00

4.05

10.6

7.4

—

Diabetic neuropathy

4.60

4.03

12.2

8.8

—

Viral pneumonia (unknown virus, not influenza)

10.02

4.01

16.4

11.0

—

Other disorders of urethra and urinary system

2.70

3.94

9.5

7.6

—

Operations 2 for CAVS

4.44

3.90

6.9

9.7

—

Calcific aortic valvular stenosis, diagnosis (helper)

4.44

3.90

6.9

9.7

—

Other endocrine disorders

9.60

3.90

5.3

4.7

—

Calcific aortic valvular stenosis, including rheumatic fever

4.44

3.90

6.9

9.7

—

Ischaemic Stroke, excluding all haemorrhages

2.73

3.86

6.5

10.6

—

Other follicular disorders

12.02

3.76

9.5

6.0

—

Thyroiditis, ILD-related definition

12.01

3.76

5.8

9.6

—

Other metabolic disorders

12.01

3.76

7.8

2.6

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

4.64

3.75

5.0

5.6

—

Disorders of skin appendages

2.82

3.74

11.9

7.3

—

Disorders of gallbladder, biliary tract and pancreas

2.25

3.69

8.1

9.4

—

Erosion of teeth , including avohilmo

3.83

3.68

10.4

9.8

—

Viral warts

6.68

3.67

5.0

7.8

—

Dental operations

3.60

3.67

7.6

5.3

—

Calcific aortic valvular stenosis, operated

4.13

3.66

6.9

9.1

—

Calcific aortic valvular stenosis

4.13

3.66

6.9

9.1

—

Constipation

2.26

3.65

9.0

8.4

—

Myocardial infarction, with ST-elevation

5.63

3.65

9.9

9.4

—

Symptoms and signs involving the urinary system

2.38

3.61

10.6

8.4

—

Abnormal findings on diagnostic imaging of lung

2.86

3.58

6.8

10.4

—

Sarcoidosis

7.79

3.55

10.3

10.1

—

Disorders of sclera, cornea, iris and ciliary body

2.57

3.54

4.7

8.7

—

Crowding of teeth, including avohilmo

8.29

3.54

2.3

4.4

—

Gingivitis and periodontal diseases

2.29

3.53

7.7

9.7

—

Arthropathies

2.43

3.52

7.9

8.4

—

Sensorineural hearing loss

2.43

3.51

8.5

9.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

4.28

3.51

5.0

5.8

—

Inguinal hernia

2.54

3.48

6.4

8.7

—

Hernia

2.21

3.38

9.1

8.3

—

Status post-ami

7.59

3.32

2.6

3.3

—

Diseases of the ear and mastoid process

2.11

3.32

7.2

8.2

—

Asthma (mode)

3.15

3.32

6.0

7.0

—

Benign neoplasm: Colon, unspecified

4.35

3.30

8.2

7.5

—

Diseases of oral cavity, salivary glands and jaws

4.12

3.28

5.8

8.7

—

Coagulation defects, purpura and other haemorrhagic conditions

4.74

3.23

4.2

8.8

—

Chronic periodontitis, complicated

2.51

3.20

8.6

9.4

—

Bacterial, viral and other infectious agents, including avohilmo

5.34

3.19

10.1

8.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

5.34

3.19

12.5

8.3

—

Open wound of ankle and foot

6.37

3.18

9.9

7.5

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

3.25

3.13

10.2

8.8

—

Other skin changes

4.50

3.11

7.8

7.4

—

Conductive and sensorineural hearing loss

2.28

3.09

8.5

9.6

—

Impotence

7.52

3.05

9.0

7.8

—

Benign neoplasm of other and unspecified endocrine glands

7.51

3.05

3.5

9.9

—

Misadventures to patients during surgical and medical care

7.51

3.05

5.0

11.1

—

Squamous cell neoplasms and carcinomas of the skin

7.50

3.05

22.5

5.1

—

All influenza (not pneumonia)

5.84

3.02

9.7

7.1

—

Type 2 diabetes, strict (exclude DM1)

2.67

3.01

8.1

8.3

—

Type 2 diabetes, definitions combined

2.67

3.01

8.1

8.3

—

Type 1 diabetes, strict (exclude DM2)

5.82

3.01

5.1

9.4

—

Type 1 diabetes, definitions combined

5.82

3.01

5.1

9.4

—

Other maternal disorders predominantly related to pregnancy

3.57

3.01

7.3

6.1

—

Dental caries, including avohilmo

2.56

3.00

8.1

5.9

—

Other and unspecified tonsillitis

3.66

2.99

11.0

7.7

—

Asthma, unspecified (mode), excluding more controls

3.75

2.99

6.7

7.7

—

Other respiratory disorders and diseases

4.29

2.99

15.6

8.5

—

Other diseases of the respiratory system

4.29

2.99

15.6

8.5

—

Fibrosis and cirrhosis of liver

10.01

2.98

4.2

10.0

—

Other infectious diseases

10.01

2.98

16.4

8.4

—

Cardiomyopathy, other and unspecified

10.01

2.98

9.6

5.8

—

Gonarthrosis, primary, with knee surgery

0.00

2.97

0.0

10.2

—

Non-allergic asthma (mode), excluding more controls

9.91

2.96

6.6

10.8

—

Keratitis

2.83

2.91

4.5

9.1

—

Asthma-related pneumonia

2.82

2.89

5.8

9.0

—

Asthma-related pneumonia or sepsis

2.82

2.89

5.8

9.0

—

Asthma, hospital admissions 3, pneumonia

2.82

2.89

5.8

9.0

—

Haemorrhage from respiratory passages

3.48

2.88

10.9

10.8

—

Other or unspecified ileus, impaction or obstruction

5.39

2.86

10.7

9.4

—

Type 2 diabetes, definitions combined, including avohilmo

2.59

2.84

8.1

8.2

—

Short stature, not elsewhere classified

9.31

2.84

2.4

1.8

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

104

2.02

2.84

6.6

9.0

—

Bacterial pneumonia (organism specified)

2.70

2.83

9.4

8.6

—

Other soft tissue disorders, not elsewhere classified

2.07

2.83

8.9

8.1

—

Nonorganic sleeping disorders, excluding more controls

4.45

2.79

6.1

12.1

—

Other and unspecified polyneuropathies, also in other diseases

3.92

2.77

14.8

9.5

—

Unspecified fall

2.45

2.75

8.1

8.4

—

Pyogenic arthritis

8.34

2.75

14.8

20.5

—

Nonischemic cardiomyopathy

8.33

2.75

3.6

16.7

—

Venous thromboembolism

2.53

2.74

8.7

8.4

—

Missing teeth due to accident, extraction or parodontitis

2.33

2.73

9.9

9.6

—

Non-allergic asthma (mode)

8.26

2.73

6.6

6.0

—

Bacterial, viral and other infectious agents

5.01

2.72

11.3

7.5

—

Other and unspecified iron deficiency

3.23

2.71

11.2

7.8

—

Abnormal findings on examination of blood, without diagnosis

2.45

2.71

8.4

9.9

—

Allergic asthma (mode), excluding more controls

8.13

2.70

4.6

5.8

—

Duodenal ulcer

6.01

2.69

12.8

10.6

—

Other symptoms and signs involving the digestive system and abdomen

6.00

2.69

9.2

8.5

—

COPD (mode)

4.46

2.69

11.6

8.9

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

5.94

2.67

22.5

4.9

—

Depression

2.02

2.66

7.6

8.7

—

Asthma-related infections

2.28

2.65

6.2

8.5

—

Asthma, hospital admission 2, infections

2.28

2.65

6.2

8.5

—

Diverticular disease of intestine

2.32

2.64

7.0

9.5

—

Other blood glucose lowering drugs, excl. Insulins

4.67

2.59

14.0

6.0

—

Diagnoses used for exclusion with ILD

3.60

2.57

10.6

9.4

—

Ventral hernia

4.00

2.56

10.1

8.9

—

Asthma, unspecified (mode)

3.17

2.55

6.7

7.0

—

Pain (limb, back, neck, head abdominally)

2.28

2.53

8.8

9.9

—

Fracture of lower leg, including ankle

2.34

2.52

14.1

8.2

—

Zoster [herpes zoster], including avohilmo

2.50

2.51

6.9

8.5

—

Later onset COPD, excluding more controls

5.72

2.50

10.3

10.4

—

In situ neoplasms

2.97

2.48

7.1

10.5

—

Aortic valve malfunction, age under 60 years

4.38

2.47

9.4

11.8

—

Other diseases of blood and blood-forming organs, wide

3.81

2.46

4.8

8.4

—

Diseases of liver

2.67

2.44

8.1

8.8

—

Type of accident

2.90

2.41

9.9

9.1

—

Acne

4.98

2.39

19.8

4.4

—

Other infectious diseases, including avohilmo

6.26

2.37

16.4

10.8

—

Zoster [herpes zoster]

4.12

2.36

4.9

7.7

—

Seborrhoeic keratosis

4.12

2.36

12.9

9.0

—

Pulmonary heart disease, diseases of pulmonary circulation

3.03

2.35

5.0

9.7

—

Cough

2.85

2.35

8.6

7.8

—

Other viral diseases

2.60

2.34

11.4

8.8

—

Benign neoplasm of colon, rectum, anus and anal canal

2.21

2.30

7.2

10.4

—

Nonsuppurative otitis media

3.25

2.29

3.8

9.0

—

Pain, not elsewhere classified

3.48

2.26

5.6

9.2

—

Paralytic ileus and intestinal obstruction

3.48

2.26

9.6

8.9

—

Other reaction to severe stress, and adjustment disorders

2.55

2.26

6.8

9.5

—

Mood disorders, excluding more controls

1.93

2.25

7.2

9.1

—

Exposure to other specified factors

102

1.93

2.24

9.4

8.4

—

Polyneuropathies and other disorders of the peripheral nervous system

3.11

2.22

14.8

9.1

—

Urinary track infection

3.47

2.22

8.3

5.2

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

5.56

2.21

12.4

8.9

—

Mycoses

2.86

2.20

9.9

8.6

—

Mood [affective] disorders

1.87

2.18

7.6

8.6

—

Embedded and impacted teeth

2.90

2.18

5.5

8.9

—

Exclusions for E4_PCOS_BROAD

3.33

2.17

6.8

9.6

—

Mood disorders

1.87

2.17

7.6

8.6

—

Actinic keratosis

2.84

2.16

7.3

8.2

—

Skin changes due to chronic exposure to nonionizing radiation

2.83

2.15

7.3

8.2

—

Diseases of the respiratory system

2.73

2.15

11.3

8.2

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

3.69

2.15

9.4

10.5

—

2.81

2.13

7.3

8.2

—

Neoplasms

2.04

2.12

10.0

7.3

—

Other/unspecified dorsalgia

2.59

2.10

12.4

9.1

—

Corneal ulcer

3.20

2.09

4.0

9.1

—

External causes of morbidity and mortality

2.29

2.08

6.9

7.1

—

Degeneration of macula and posterior pole

2.50

2.07

6.4

9.9

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.31

2.07

10.4

7.8

—

Other diseases of pancreas

5.01

2.07

15.0

6.5

—

Disorders of continuity of bone

5.00

2.07

8.4

6.5

—

Other embolism and thrombosis

5.00

2.07

5.0

10.8

—

Other diseases of liver

3.50

2.05

10.7

9.7

—

Leisure time condition

3.50

2.05

13.9

8.6

—

Psychiatric diseases

1.86

2.04

7.6

9.0

—

Disease of hard tissues of teeth, NOS

3.14

2.04

6.9

8.7

—

Allergic asthma (mode)

4.88

2.03

4.6

4.8

—

Sleep apnoea

1.87

2.01

9.0

8.8

—

Nonorganic sleeping disorders

3.08

2.01

6.1

9.0

—

Fracture of foot, except ankle

2.81

2.00

12.0

9.4

—

Disorders of synovium and tendon

2.24

1.98

10.6

9.0

—

Gonarthrosis,primary

0.35

1.96

2.4

9.8

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.08

1.95

7.9

8.1

—

Artificial joint operation, meniscal resection

0.34

1.94

6.8

9.7

—

Malignant neoplasm of urinary organs, including Hilmo

4.55

1.94

12.4

9.1

—

Melanocytic naevi of trunk

4.55

1.94

8.0

7.5

—

Candidiasis

4.55

1.94

8.4

10.0

—

Valvular operations

4.55

1.94

9.0

5.7

—

Open wound of lower leg

3.75

1.93

5.5

8.8

—

Irregular menses

2.82

1.93

7.7

7.5

—

Presence of other devices

4.47

1.91

2.8

10.7

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

4.47

1.91

8.4

6.3

—

Other neurological diseases

1.99

1.90

6.2

9.8

—

Atopic dermatitis, strict definition with reimbursement

2.70

1.90

14.0

8.8

—

Aortic aneurysm

3.68

1.89

5.3

9.7

—

2.22

1.87

6.4

8.7

—

Superficial injury of lower leg

2.86

1.86

9.1

8.4

—

Convulsions, not elsewhere classified

3.14

1.85

7.1

8.0

—

Unstable angina pectoris

3.23

1.85

3.7

11.9

—

Acute appendicitis

1.94

1.83

9.6

8.4

—

Injuries to the ankle and foot

1.88

1.83

10.1

7.4

—

Diabetes mellitus in pregnancy

3.81

1.83

15.3

5.0

—

Chronic lower respiratory diseases

1.68

1.82

7.1

8.8

—

Codeine or tramadol medication

1.75

1.81

8.3

9.7

—

Delivery

0.00

1.81

0.0

8.0

—

Single spontaneous delivery

0.00

1.81

0.0

8.0

—

Polycystic ovarian syndrome, consortium definition

2.37

1.76

9.8

7.4

—

Injuries to the knee and lower leg

1.68

1.73

10.1

8.0

—

Adhesive capsulitis of shoulder

3.85

1.71

12.0

12.8

—

Other diseases of urinary system

1.77

1.71

9.3

8.5

—

Visual disturbances

2.13

1.71

5.8

8.6

—

Lyme disease

0.00

1.70

0.0

8.4

—

Lyme disease, including avohilmo

0.00

1.70

0.0

8.4

—

Spirochaetal infections, other/unspecified, including avohilmo

0.00

1.70

0.0

8.4

—

Other spirochaetal diseases

0.00

1.70

0.0

8.4

—

Other spirochaetal diseases, including avohilmo

0.00

1.70

0.0

8.4

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.67

1.69

10.0

7.2

—

Diseases of middle ear and mastoid

1.98

1.69

9.4

8.1

—

Other disorders of ear

1.77

1.68

7.8

9.6

—

Sequelae of cerebrovascular disease

2.51

1.66

11.1

11.2

—

Viral warts, including avohilmo

2.58

1.65

5.0

9.2

—

Other viral diseases, including avohilmo

2.16

1.63

11.4

8.7

—

Reimbursement for rheumatic diseases

2.02

1.61

3.9

8.9

—

Nontraumatic intracranial haemmorrhage

3.57

1.61

7.8

9.6

—

Caries of dentine, including avohilmo

1.92

1.59

8.2

6.0

—

Cardiodefibrillation

2.32

1.58

6.9

8.7

—

Acute appendicitis, with complications

3.00

1.58

9.8

10.6

—

Adverse effects, not elsewhere classified

3.00

1.58

4.2

7.2

—

Soft tissue disorders

1.71

1.56

6.8

8.0

—

Injuries to the elbow and forearm

1.87

1.56

10.0

8.0

—

Fracture of shoulder and upper arm

2.20

1.56

14.9

8.3

—

Appendicitis, broad definition

1.81

1.53

9.6

8.7

—

Otitis externa

2.59

1.51

17.6

8.1

—

Combinations of oral blood glucose lowering drugs

2.59

1.51

7.3

9.7

—

severe traumatic brain injury, does not include concussion

2.59

1.51

4.3

9.3

—

Diseases of the musculoskeletal system and connective tissue

2.23

1.51

3.9

9.1

—

Cervicobrachial syndrome

2.86

1.50

8.7

9.1

—

Excessive attrition of teeth

1.90

1.49

11.7

8.2

—

2.86

1.48

6.3

8.4

—

Examination and observation for other reasons

2.10

1.48

7.9

10.1

—

Diseases of appendix

1.79

1.47

9.6

9.3

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.22

1.46

8.0

7.8

—

Other noninfective gastroenteritis and colitis

2.50

1.45

5.0

8.2

—

Osteoporosis

2.76

1.43

10.7

7.0

—

Unspecified acute lower respiratory infection

2.73

1.43

11.3

8.7

—

Atopic dermatitis, strict definition

2.32

1.43

14.0

7.1

—

Impacted teeth

2.50

1.43

6.6

8.3

—

Visual disturbances and blindness

1.97

1.42

5.8

8.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.67

1.42

6.6

10.0

—

Headache

2.06

1.41

9.2

6.8

—

Anxiety disorders, excluding more controls

1.76

1.40

9.4

8.6

—

Fracture of femur

2.43

1.38

14.7

6.0

—

Alzheimer disease, including avohilmo

0.00

1.38

0.0

7.3

—

Injuries to the thorax

2.00

1.37

14.3

9.0

—

Use of hypnotics and sedatives

1.62

1.37

8.6

9.0

—

Other respiratory diseases principally affecting the interstitium

2.94

1.36

11.0

8.2

—

Benign neoplasm: Colon

1.94

1.36

7.2

10.2

—

Pre-eclampsia or poor fetal growth

2.93

1.35

10.2

7.3

—

Suppurative and unspecified otitis media

2.16

1.35

9.2

—

Nonsuppurative otitis media, including avohilmo

2.16

1.33

3.8

9.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.57

1.32

7.8

8.1

—

Symptoms and signs involving the skin and subcutaneous tissue

1.72

1.32

7.6

9.0

—

Anxiety disorders

1.65

1.29

8.7

7.9

—

Later onset COPD

2.54

1.29

10.3

8.4

—

Retinal detachments and breaks

2.29

1.26

12.0

10.5

—

Intestinal stricture

2.29

1.26

9.6

8.8

—

COPD related to multimorbidity

2.06

1.26

10.4

7.8

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

2.26

1.24

8.9

7.7

—

Acute suppurative otitis media

2.19

1.22

6.4

8.7

—

Sleep apnoea, including avohilmo

1.60

1.22

8.7

8.6

—

Other gastritis (incl. Duodenitis)

2.63

1.21

14.0

8.1

—

Preterm labour and delivery

2.63

1.21

13.8

6.6

—

Other disorders of penis

2.63

1.21

4.2

7.8

—

Other and unspecified effects of external causes

2.16

1.21

6.1

8.3

—

Congenital malformations, deformations and chromosomal abnormalities

1.75

1.19

5.7

8.0

—

Fall on same level

1.53

1.18

12.3

7.0

—

Obesity related asthma

2.11

1.18

8.8

9.8

—

Degenerative diseases of the nervous system

0.00

1.18

0.0

7.0

—

Transient ischemic attack

1.85

1.18

5.5

10.6

—

Sleep disorders (combined)

1.54

1.17

9.9

8.4

—

Fenamates

0.00

1.16

0.0

5.8

—

Diseases of external ear

2.00

1.16

15.8

7.7

—

Abnormal spermatozoa

2.50

1.15

11.8

8.3

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.50

1.15

7.6

11.3

—

Covid-19 suspected case

2.50

1.15

4.2

6.8

—

Acne, including avohilmo

2.36

1.13

19.3

7.1

—

Other viral diseases, not elsewhere classified

2.33

1.12

12.6

9.0

—

Persons encountering health services for examination and investigation

1.86

1.10

9.4

10.1

—

Benign neoplasms

1.57

1.10

6.5

10.0

—

Other diseases of anus and rectum

2.25

1.10

5.6

8.5

—

Burns and corrosions

2.38

1.09

8.6

9.6

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.95

1.08

11.8

8.2

—

Syncope and collapse

1.96

1.08

10.6

7.3

—

Gestational diabetes (for exclusion)

2.46

1.08

12.6

6.2

—

Other viral diseases, not elsewhere classified, including avohilmo

1.94

1.07

11.1

8.3

—

Neurotic, stress-related and somatoform disorders

1.58

1.07

7.4

8.3

—

Other antidepressants

1.53

1.06

6.1

9.3

—

Intracranial trauma

1.79

1.05

9.2

8.0

—

Shoulder lesions

1.68

1.04

7.3

9.2

—

Persons encountering health services in circumstances related to reproduction

0.46

1.04

9.8

7.9

—

Follicular cysts of skin and subcutaneous tissue

2.27

1.03

12.4

9.9

—

Acute and subacute iridocyclitis

2.27

1.03

4.4

10.0

—

Asthma/COPD (KELA code 203)

1.53

1.03

7.0

8.9

—

Delivery, wide proxy

0.00

1.03

0.0

8.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.94

1.01

16.1

7.7

—

Alzheimer disease

0.00

1.00

0.0

7.5

—

Fracture at wrist and hand level

1.88

1.00

10.4

7.6

—

Infections with a predominantly sexual mode of transmission

2.00

0.99

17.6

8.5

—

Falls/tendency to fall

1.49

0.99

12.1

6.5

—

Other degenerative diseases of the nervous system

0.00

0.99

0.0

11.4

—

Ovarian cyst

2.45

0.98

3.8

9.0

—

Anterior Iridocyclitis

2.17

0.98

4.4

9.6

—

Stomatitis and related lesions

2.17

0.98

8.6

8.2

—

Other strabismus

0.00

0.97

0.0

7.5

—

Gastro-oesophageal reflux disease

1.64

0.97

11.0

8.4

—

Excessive earwax

1.64

0.96

13.3

8.6

—

Anxiety (asthma-related co-morbidities)

1.70

0.93

5.8

8.1

—

Subjective visual disturbances

2.22

0.93

3.7

8.1

—

Cholelithiasis

1.61

0.92

7.4

9.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.82

0.92

11.2

8.5

—

Pain in throat and chest

1.64

0.92

3.8

9.0

—

DVT of lower extremities and pulmonary embolism

1.72

0.91

6.1

9.3

—

Phlebitis and thrombophlebitis (not including DVT)

2.14

0.91

12.5

10.4

—

Pregnancy hypertension

2.14

0.91

8.2

8.4

—

Periapical abscess

1.75

0.90

10.1

8.7

—

Appendectomy

1.62

0.89

13.9

7.9

—

Specific personality disorders

2.07

0.89

4.2

10.8

—

Any mental disorder

1.48

0.89

6.8

8.9

—

COPD

1.80

0.87

10.0

10.3

—

Benign paroxysmal vertigo

2.00

0.87

6.3

9.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.57

0.84

5.7

7.7

—

Antenatal screening

0.00

0.83

0.0

9.3

—

Injuries to the hip and thigh

1.70

0.82

12.1

8.1

—

Pulmonary embolism

1.87

0.81

5.2

9.9

—

Asthma, hospital admissions , main diagnosis only

105

1.49

0.81

6.5

8.7

—

Noninflammatory disorders of female genital tract

0.00

0.81

0.0

8.5

—

1.58

0.81

7.9

9.3

—

Haemorrhoids and perianal venous thrombosis

1.86

0.81

15.5

8.4

—

Substance abuse, excluding more controls

1.64

0.79

9.0

9.4

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.79

0.0

9.3

—

Neurological diseases

1.49

0.78

11.5

7.5

—

Fracture of forearm

1.67

0.78

12.8

7.8

—

Biguanides

1.51

0.77

9.5

9.3

—

COPD, hospital admission 2, with asthma infections

1.78

0.76

7.8

7.7

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.76

0.76

4.0

10.4

—

Glucagon-like peptide-1 (GLP-1) analogues

1.76

0.76

4.0

10.4

—

Pulmonary heart disease

1.76

0.76

5.2

9.1

—

Other chronic obstructive pulmonary disease

1.67

0.74

10.4

10.5

—

Disorders of conjunctiva

103

0.60

0.74

12.9

7.7

—

Poisoning by medicine

2.08

0.74

9.8

11.1

—

Fibroblastic disorders

2.08

0.74

9.4

10.8

—

Other dorsopathies, not elsewhere classified

1.43

0.74

9.3

8.8

—

Diseases of male genital organs

1.50

0.73

11.1

8.0

—

Liquid cancers

1.84

0.73

13.0

6.9

—

Other specific joint derangements/joint disorders

1.59

0.73

8.0

8.5

—

Transport accidents

1.63

0.73

13.6

4.8

—

Acute appendicitis, no complications

1.59

0.73

9.5

8.3

—

Iridocyclitis

2.00

0.72

4.4

10.4

—

Poisoning by drugs, medicaments and biological substances

2.00

0.72

9.8

10.8

—

Cholelithiasis, broad definition with cholecystitis

1.50

0.72

7.4

9.3

—

Retention of urine

1.77

0.71

10.0

8.4

—

Other hearing loss

1.94

0.71

7.8

8.4

—

Mouth breathing

1.58

0.71

12.0

8.2

—

1.52

0.70

7.9

9.3

—

Functional dyspepsia

1.92

0.70

6.8

7.7

—

Melanocytic naevi

1.71

0.69

7.0

8.8

—

COPD, hospital admissions

1.55

0.69

10.4

9.9

—

Nerve, nerve root and plexus disorders

1.39

0.69

10.4

8.9

—

Urolithiasis

1.67

0.68

12.6

7.7

—

Inflammatory bowel disease

1.63

0.66

6.9

9.6

—

Tinnitus

1.79

0.66

4.4

9.6

—

Injuries to the neck

1.79

0.66

11.6

9.1

—

Other extrapyramidal and movement disorders in other diseases

1.72

0.64

5.4

8.5

—

Candidiasis, including avohilmo

1.72

0.64

8.4

9.1

—

Necrosis of pulp, including avohilmo

1.49

0.63

8.4

—

Female infertility

0.00

0.62

0.0

9.6

—

Single delivery by forceps and vacuum extractor

0.00

0.62

0.0

7.9

—

Alzheimer disease, excluding more controls

0.00

0.62

0.0

9.1

—

Accidents

1.46

0.62

10.6

5.7

—

Other external causes of accidental injury

1.46

0.62

10.6

5.7

—

Supervision of high-risk pregnancy

0.00

0.61

0.0

9.3

—

Other disorders of eyelid

1.61

0.61

8.6

8.7

—

Noninfective enteritis and colitis

1.59

0.61

7.4

8.3

—

Special screening examination for infectious and parasitic diseases

0.00

0.61

0.0

8.1

—

Alzheimer’s disease (Late onset)

0.00

0.61

0.0

6.9

—

Alzheimer’s disease, strict definition

0.00

0.61

0.0

6.9

—

Use of memantine

0.00

0.61

0.0

6.9

—

Use of other anti-dementia drugs

0.00

0.61

0.0

6.9

—

Supervision of normal pregnancy

0.00

0.60

0.0

9.3

—

Injuries to the shoulder and upper arm

100

1.39

0.60

13.8

8.0

—

Hallux valgus (acquired)

0.00

0.59

0.0

10.8

—

Postpartum haemorrhage

0.00

0.59

0.0

5.3

—

Episodal and paroxysmal disorders

1.34

0.58

10.4

8.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.74

0.58

2.8

7.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.50

0.58

7.9

—

Disorders of adult personality and behaviour

1.71

0.57

4.2

9.7

—

All anxiety disorders

1.46

0.56

5.8

7.9

—

Spinal stenosis

1.54

0.55

4.7

10.1

—

Malignant neoplasm of skin

1.52

0.55

8.0

8.3

—

Conjunctivitis

0.65

0.55

12.9

7.4

—

COPD, early/later onset

1.51

0.54

10.4

9.7

—

Malignant neoplasm of skin, including Hilmo

1.56

0.54

7.9

8.0

—

Cystitis

1.42

0.53

7.8

8.1

—

Concussion

1.42

0.52

10.3

8.0

—

Calculus of kidney and ureter

1.50

0.51

14.3

7.8

—

Abrasion of teeth

1.50

0.51

6.3

9.2

—

Benzodiazepine use

102

1.32

0.51

10.1

8.7

—

Fracture of rib(s), sternum and thoracic spine

1.46

0.50

12.5

8.5

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.46

0.50

11.2

8.6

—

Dermatophytosis, including avohilmo

106

0.65

0.48

4.3

8.8

—

Caries of enamel

1.32

0.48

3.9

9.6

—

Glaucoma

1.49

0.48

15.7

9.0

—

Injury, poisoning and certain other consequences of external causes

1.52

0.47

5.1

7.8

—

Dorsalgia

1.32

0.47

11.3

8.8

—

Dorsopathies

1.31

0.47

8.4

8.7

—

Rotator cuff syndrome

1.46

0.47

5.7

9.3

—

Alcohol use disorder, Swedish definition

1.42

0.46

5.7

10.0

—

Carpal tunnel syndrome

1.44

0.46

8.5

—

Basal cell carcinoma

1.45

0.46

6.9

7.1

—

Substance abuse

1.41

0.46

9.0

9.4

—

Conjunctivitis (acute, non atopic), including avohilmo

114

0.74

0.46

11.6

8.3

—

Dental pulpitis, including avohilmo

1.31

0.45

13.9

8.0

—

Liquid cancers, including Hilmo

1.40

0.45

13.0

7.3

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.38

0.44

19.7

7.4

—

Postmenopausal bleeding

0.00

0.43

0.0

5.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

1.61

0.43

15.2

7.4

—

Disturbances of skin sensation

1.61

0.43

7.2

9.5

—

Chronic diseases of tonsils and adenoids

1.33

0.42

3.9

8.7

—

Chronic sinusitis

1.43

0.42

4.8

8.1

—

Speech therapy

1.56

0.42

3.8

9.2

—

Outcome of delivery

0.00

0.42

0.0

10.3

—

Dementia in Alzheimer disease

0.00

0.41

0.0

8.2

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.41

0.0

9.2

—

Postpartum hemorraghe, all women as controls

0.00

0.41

0.0

9.7

—

Female infertility, cervical, vaginal, other or unspecified origin

0.00

0.41

0.0

9.5

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

0.41

0.0

7.7

—

Other disorders of conjunctiva

0.00

0.41

0.0

8.1

—

Postpartum hemorraghe, parous women as controls

0.00

0.40

0.0

8.4

—

Fracture of skull and facial bones

1.47

0.40

7.8

8.9

—

Ulcerative colitis

1.47

0.40

8.6

9.6

—

Persistent mood disorders

0.00

0.40

0.0

11.1

—

Depression or dysthymia

1.36

0.39

7.9

9.8

—

Urticaria

1.43

0.39

4.6

8.2

—

Lichen planus, including avohilmo

0.00

0.39

0.0

7.7

—

Low back pain

1.33

0.38

8.4

9.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.35

0.38

6.6

9.8

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.48

0.36

7.0

10.1

—

Fall on same level involving ice and snow

1.39

0.36

13.5

8.4

—

Mental and behavioural disorders due to psychoactive substance use

1.34

0.36

9.0

9.3

—

Other arrhythmias

1.44

0.36

6.7

10.4

—

Tonsillectomy and adenotomy

1.35

0.36

2.9

8.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.66

0.35

11.8

9.3

—

Non-selective monoamine reuptake inhibitors

1.44

0.35

9.3

9.2

—

Arthrosis

1.40

0.35

6.8

10.3

—

Pain in joint

1.40

0.35

8.9

9.8

—

Glaucoma suspect

1.39

0.35

14.2

9.4

—

Conjunctivitis (acute, non atopic)

1.39

0.35

16.8

8.7

—

Artrosis, including avohilmo

0.75

0.34

6.4

9.8

—

Cholecystectomy

1.33

0.32

8.5

8.4

—

Other arthrosis

1.38

0.32

6.7

10.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.36

0.31

17.6

8.4

—

Atopic dermatitis

1.35

0.31

12.8

7.0

—

Asthma (diagnoses ohter than nonallergic)

111

1.24

0.30

5.2

9.1

—

Basal cell carcinoma, including Hilmo

1.28

0.30

6.9

8.3

—

Meniscus derangement

1.25

0.29

5.1

10.5

—

Disorders of vestibular function (Vertigo)

1.24

0.29

7.7

9.0

—

Other intervertebral disc disorders

1.26

0.28

8.6

9.6

—

Any event in cancer register

1.22

0.27

7.1

7.6

—

Hyperplasia of prostate

1.22

0.27

18.4

10.3

—

Diseases of inner ear

1.23

0.27

10.9

8.5

—

Other anxiety disorders

1.19

0.26

5.6

8.5

—

Injuries to the wrist and hand

105

1.20

0.26

9.0

8.6

—

Other chronic obstructive pulmonary disease, including avohilmo

1.23

0.25

10.4

9.6

—

Mental and behavioural disorders due to alcohol

1.29

0.24

8.0

9.5

—

Lumbar disc prolapse

1.27

0.24

9.4

9.8

—

Dislocation, sprain and strain of joints and ligaments of knee

0.71

0.24

14.0

7.9

—

Other disorders of lacrimal gland

1.32

0.23

8.2

8.6

—

Disorders of refraction and accommodation

1.24

0.22

6.2

8.3

—

Malignant neoplasm

1.20

0.22

7.4

7.8

—

Malignant neoplasm

1.20

0.22

7.4

7.8

—

Other and unspecified disorders of vitreous body

1.19

0.21

9.2

8.6

—

Malignant neoplasm of bladder, including Hilmo

0.00

0.21

0.0

10.5

—

Foreign body or object entering through skin

0.00

0.21

0.0

9.0

—

Multiple delivery

0.00

0.21

0.0

9.1

—

Ankylosing spondylitis, ICD10

0.00

0.21

0.0

8.4

—

Other appendicitis

0.00

0.21

0.0

8.8

—

Mental disorders, not otherwise specified

0.00

0.21

0.0

9.1

—

L02BB Anti-androgens

0.00

0.21

0.0

5.6

—

Other psoriatic arthropathies

0.00

0.21

0.0

5.9

—

Cervicocranial syndrome

0.00

0.21

0.0

7.4

—

Chalazion

0.00

0.21

0.0

11.0

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

0.21

0.0

6.7

—

Contact with other sharp object(s)

0.00

0.21

0.0

7.8

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

7.8

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

8.8

—

Ankylosing spondylitis

0.00

0.21

0.0

10.0

—

Psoriatic arthropathies, ICD10

0.00

0.21

0.0

7.5

—

Adalimumab

0.00

0.21

0.0

8.6

—

Injury of muscle and tendon at hip and thigh level

0.00

0.21

0.0

9.7

—

Monoamine oxidase A inhibitors

0.00

0.21

0.0

12.6

—

Bitten or struck by other mammals

0.00

0.21

0.0

5.8

—

Budesonide

0.00

0.21

0.0

7.1

—

Use of rivastigmine

0.00

0.21

0.0

7.2

—

Prolonged pregnancy

0.00

0.21

0.0

5.5

—

Malignant neoplasm of breast, HER-negative

0.00

0.21

0.0

6.4

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

0.21

0.0

6.4

—

Other benign neoplasms of skin

1.16

0.21

5.0

9.0

—

Urticaria and erythema

1.16

0.21

4.6

7.9

—

Pregnancy examination and test

0.00

0.21

0.0

10.2

—

Contact with and exposure to communicable diseases

1.16

0.21

7.0

9.4

—

Perineal laceration during delivery

0.00

0.21

0.0

4.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

9.0

—

Bell's palsy

0.00

0.21

0.0

9.8

—

ILD, hospital admissions 1, main diag only

0.00

0.21

0.0

8.1

—

Lateral epicondylitis

0.00

0.21

0.0

14.2

—

ILD, hospital admissions

0.00

0.21

0.0

8.1

—

Interstitial lung disease

0.00

0.21

0.0

8.1

—

Other interstitial pulmonary diseases

0.00

0.21

0.0

8.1

—

Interstitial lung disease endpoints

0.00

0.21

0.0

8.1

—

Medical treatment for female infertility

0.00

0.20

0.0

9.8

—

Use of disulfiram, acamprosate or naltrexone

0.00

0.20

0.0

9.3

—

Spondylopathies (FG)

0.00

0.20

0.0

10.9

—

Retinal breaks without detachment

0.00

0.20

0.0

12.1

—

Leiomyoma of uterus

1.20

0.20

8.3

8.4

—

Coxarthrosis [arthrosis of hip](FG)

1.21

0.20

11.5

11.2

—

Extrapyramidal and movement disorders

1.22

0.20

5.0

9.4

—

Selective serotonin reuptake inhibitors

0.83

0.19

8.5

9.2

—

Malignant neoplasm, including Hilmo

1.18

0.19

7.4

7.7

—

Exclusions for E4_PCOS_CONSORTIUM

1.23

0.18

6.8

8.7

—

Sciatica+with lumbago

0.76

0.17

5.6

8.9

—

Intracranial injury

1.21

0.17

9.0

8.0

—

Malignant neoplasm, wide definition

1.16

0.17

7.4

7.6

—

Asthma, including avohilmo

107

1.13

0.16

6.1

9.0

—

Injuries to the head

110

1.13

0.16

9.8

8.2

—

Coxarthrosis

1.08

0.09

13.4

11.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.07

0.08

6.2

9.6

—

Other symptoms and signs involving cognitive functions and awareness

0.79

0.08

4.8

8.2

—

Other inflammation of eyelid, including avohilmo

0.79

0.08

1.4

8.3

—

Organic, including symptomatic, mental disorders

1.09

0.08

8.1

—

Alcohol use disorder, ICD-based

1.08

0.08

5.3

9.9

—

Migraine

1.05

0.08

13.6

6.7

—

Solid cancers

1.11

0.08

8.2

8.1

—

Other diseases of upper respiratory tract

1.09

0.08

8.7

8.9

—

Coxarthrosis, primary

0.80

0.07

11.5

9.4

—

Open wound of head

0.85

0.06

9.6

8.2

—

Disorders of eyelid, lacrimal system and orbit

0.92

0.05

6.6

9.3

—

Other joint disorders

1.10

0.04

6.2

8.4

—

Dizziness and giddiness

0.91

0.04

14.5

8.5

—

Mycoses, including avohilmo

114

0.93

0.04

7.6

8.7

—

Solid cancers, including Hilmo

1.07

0.03

8.2

7.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

0.95

0.01

7.9

8.6

—

Sleep disorders

0.95

0.01

6.6

8.6

—

Lower back pain or/and sciatica

103

1.03

0.00

7.1

9.4

—

Spondylopathies

1.03

0.00

7.5

9.3

—

Insomnia

0.98

0.00

6.6

8.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.03

0.00

7.2

8.3

—

Dentofacial anomalies [including malocclusion]

0.98

0.00

16.9

8.2

—

Lichen planus

0.00

0.0

9.0

—

Other disorders of amniotic fluid and membranes

0.00

0.0

6.1

—

Malignant neoplasm of bladder

0.00

0.0

5.5

—

Malignant neoplasm of corpus uteri

0.00

0.0

4.4

—

Rubella [German measles]

0.00

0.0

3.8

—

Struck by thrown, projected or falling objec

0.00

0.0

8.9

—

Other symptoms and signs involving general sensations and perceptions

0.00

0.0

8.2

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

7.3

—

Noise effects on inner ear

0.00

0.0

6.2

—

Sequelae of infectious and parasitic diseases, including avohilmo

0.00

0.0

11.0

—

Ankylosing spondylitis, strict definition

0.00

0.0

13.2

—

Contact with nonpowered hand tool

0.00

0.0

13.0

—

Glaucoma, exfoliation

0.00

0.0

7.4

—

Other and unspecified intracranial injuries

0.00

0.0

8.2

—

L04AC Interleukin inhibitors

0.00

0.0

10.9

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

0.0

10.0

—

Malignant neoplasm of digestive organs, including Hilmo

0.92

-0.00

8.8

8.2

—

Malignant neoplasm of corpus uteri, including Hilmo

0.00

-0.00

0.0

4.0

—

Infectious mononucleosis, including avohilmo

0.00

-0.00

0.0

5.4

—

Twin gestation

0.00

-0.00

0.0

8.8

—

Use of galantamine

0.00

-0.00

0.0

5.2

—

Varicose veins

0.98

-0.00

3.9

9.2

—

Helminthiases, including avohilmo

0.00

-0.00

0.0

8.6

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

10.0

—

Psoriatic and enteropathic arthropathies

0.00

-0.00

0.0

14.4

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

3.8

—

Use of biperiden

0.00

-0.00

0.0

8.6

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

10.7

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

4.8

—

Other otitis externa (chronic)

0.00

-0.00

0.0

8.4

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

6.7

—

Left ventricular outflow tract obstruction, narrow definition

0.00

-0.00

0.0

8.6

—

Divergent concomitant strabismus

0.00

-0.00

0.0

6.8

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

12.7

—

Intermittent heterotropia

0.00

-0.00

0.0

5.6

—

conjunctival haemorrhage

0.00

-0.00

0.0

4.7

—

Chromosomal abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.8

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

-0.00

0.0

5.2

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

-0.00

0.0

7.0

—

Convergent concomitant strabismus

0.00

-0.00

0.0

8.4

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

11.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

14.8

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

11.0

—

Kela-code for severe mental illness

1.02

-0.00

7.0

9.2

—

Other diseases of lip and oral mucosa

1.02

-0.00

4.8

8.8

—

Hyperkinetic disorders (excl. ADHD)

0.00

-0.00

0.0

4.3

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

-0.00

0.0

3.5

—

Event of undetermined intent

0.00

-0.00

0.0

9.9

—

Atrophic disorders of skin

0.00

-0.00

0.0

5.1

—

Caught, crushed, jammed or pinched in or between objects

0.00

-0.00

0.0

6.6

—

Unspecified mental disorder

0.98

-0.00

7.0

9.1

—

Desensitization to allergens

0.00

-0.00

0.0

4.6

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

7.1

—

Varicose veins of other sites

0.00

-0.00

0.0

9.2

—

Ulcerative proctitis

0.00

-0.00

0.0

8.2

—

Fracture of neck

0.00

-0.00

0.0

7.5

—

Flat foot [pes planus] (acquired)

0.00

-0.00

0.0

7.1

—

Drug-induced neutropenia

0.00

-0.00

0.0

8.4

—

ILD, hospital admission 2, with pulmonary infections

0.00

-0.00

0.0

9.8

—

ILD, hospital admissions 3, with pneumonia sepsis

0.00

-0.00

0.0

10.0

—

Pneumonia due to other infectious organisms, not elsewhere classified

0.00

-0.00

0.0

8.4

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

11.0

—

Hydrocephalus

0.00

-0.00

0.0

7.3

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

7.0

—

Striking against or struck by other objects

0.89

-0.00

6.8

8.2

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

14.8

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

8.5

—

Pneumothorax

0.00

-0.00

0.0

8.9

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

6.6

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

0.00

-0.00

0.0

9.7

—

Schizoaffective disorder

0.00

-0.00

0.0

9.9

—

Effects of other external causes

0.00

-0.00

0.0

4.4

—

Sequelae of infectious and parasitic diseases

0.00

-0.00

0.0

12.5

—

Endometriosis of pelvic peritoneum

0.00

-0.00

0.0

8.4

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

6.4

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

4.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

12.6

—

Psoriatic arthropathies

0.00

-0.00

0.0

15.9

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

-0.00

0.0

8.4

—

Scoliosis

0.00

-0.00

0.0

4.5

—

Traumatic amputation of wrist and hand

0.00

-0.00

0.0

6.3

—

Benign mammary dysplasia

0.00

-0.00

0.0

4.8

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

5.2

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

10.0

—

Endometriosis of rectovaginal septum and vagina

0.00

-0.00

0.0

8.4

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

7.2

—

Sequelae of injuries of head

0.00

-0.00

0.0

5.7

—

Non-small cell lung cancer

0.00

-0.00

0.0

5.7

—

Inflammatory disease of uterus

0.00

-0.00

0.0

5.7

—

Unspecified lump in breast

0.00

-0.00

0.0

6.3

—

Disorders of lacrimal system

1.00

-0.00

8.2

8.9

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

8.5

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

8.2

—

Vestibular neuronitis

0.00

-0.00

0.0

8.8

—

Benign neoplasm of meninges

0.00

-0.00

0.0

6.6

—

Carcinoma in situ, bladder

0.00

-0.00

0.0

5.2

—

Carcinoma in situ of other and unspecified sites

0.00

-0.00

0.0

5.2

—

Alcohol-induced acute pancreatitis

0.00

-0.00

0.0

7.8

—

Wide developmental disorders

0.00

-0.00

0.0

4.2

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

8.4

—

Other peripheral vertigo

0.00

-0.00

0.0

5.2

—

Generalized epilepsy

0.00

-0.00

0.0

5.7

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

9.8

—

Atrial septal defect

0.00

-0.00

0.0

4.9

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

9.9

—

Other congenital malformations of skin, including avohilmo

0.00

-0.00

0.0

9.0

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

5.7

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

-0.00

0.0

10.8

—

Multiple gestation

0.00

-0.00

0.0

8.8

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

3.9

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

-0.00

0.0

10.0

—

Recurrent dislocation and subluxation of joint

0.00

-0.00

0.0

11.3

—

Trochanteric bursitis

0.00

-0.00

0.0

6.4

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.01

-0.00

7.7

8.4

—

Spirochaetal infections, other/unspecified

0.00

-0.00

0.0

8.8

—

Polypectomy (DHB20)

0.00

-0.00

0.0

11.6

—

Infectious mononucleosis

0.00

-0.00

0.0

5.4

—

Hypogonadotropic hypogonadism

0.00

-0.00

0.0

10.8

—

Procreative management

0.91

-0.00

8.8

7.9

—

Other disorders of the genitourinary system

0.00

-0.00

0.0

5.3

—

Pain associated with micturition

0.00

-0.00

0.0

6.8

—

Other and unspecified mood [affective] disorders

0.00

-0.00

0.0

7.4

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

0.00

-0.00

0.0

4.6

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.00

-0.00

0.0

2.6

—

Heterophoria

0.00

-0.00

0.0

4.5

—

Benign neoplasm of bone and articular cartilage

0.00

-0.00

0.0

5.8

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

0.00

-0.00

0.0

6.7

—

Other complications of labour and delivery, not elsewhere classified

0.00

-0.00

0.0

6.2

—

Raynaud syndrome

0.00

-0.00

0.0

7.5

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

8.4

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS